Nativeremedies Backache Ease Tablet
NDC Package 68703-373-80
Package Information
Nativeremedies Backache Ease (arnica, bryonia, cimicifuga, hypericum, ignatia, kali carb, nux vom, rhus tox, ruta) tablets is directions: chew or dissolve tablets in the mouth. This formulation utilizes a tablet delivery system. Marketed by Silver Star Brands, this product is identified by NDC 68703-373.
Identification & Billing
Clinical Specifications
- ACTAEA CIMICIFUGA ROOT 12 [hp_C]/1801
- ARNICA ANGUSTIFOLIA FLOWER 12 [hp_C]/1801
- BRYONIA ALBA ROOT 12 [hp_C]/1801
- HYPERICUM PERFORATUM 12 [hp_C]/1801
- POTASSIUM CARBONATE 12 [hp_C]/1801
- RUTA GRAVEOLENS FLOWERING TOP 12 [hp_C]/1801
- STRYCHNOS IGNATII SEED 12 [hp_C]/1801
- STRYCHNOS NUX-VOMICA SEED 12 [hp_C]/1801
- TOXICODENDRON RADICANS LEAF 12 [hp_C]/1801
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 68703 - Silver Star Brands
- 68703-373 - Nativeremedies Backache Ease
- 68703-373-80 - 180 TABLET in 1 BOTTLE, GLASS
- 68703-373 - Nativeremedies Backache Ease
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68703-373-80 identifies a specific commercial package of 180 tablet in 1 bottle, glass of Nativeremedies Backache Ease, a human over the counter drug labeled by Silver Star Brands. This tablet is formulated for oral use and contains actaea cimicifuga root; arnica angustifolia flower; bryonia alba root; hypericum perforatum; potassium carbonate; ruta graveolens flowering top; strychnos ignatii seed; strychnos nux-vomica seed; toxicodendron radicans leaf as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Silver Star Brands on September 07, 2021. The current certification is valid through December 31, 2026.
How is this Silver Star Brands product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68703037380. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.